Abstract: The present invention relates to methods, apparatus and systems for audio playback via a personal audio device following a biometric process. A personal audio device may be used to obtain ear model data for authenticating a user via an ear biometric authentication system. Owing to that successful authentication, the electronic device is informed of the person who is listening to audio playback from the device. Thus the device can implement one or more playback settings which are specific to that authorised user.

Abstract: The present invention relates to methods, apparatus and systems for audio playback via a personal audio device following a biometric process. A personal audio device may be used to obtain ear model data for authenticating a user via an ear biometric authentication system. Owing to that successful authentication, the electronic device is informed of the person who is listening to audio playback from the device. Thus the device can implement one or more playback settings which are specific to that authorised user.

Abstract: The present invention relates to methods, apparatus and systems for audio playback via a personal audio device following a biometric process. A personal audio device may be used to obtain ear model data for authenticating a user via an ear biometric authentication system. Owing to that successful authentication, the electronic device is informed of the person who is listening to audio playback from the device. Thus the device can implement one or more playback settings which are specific to that authorised user.

Abstract: The present invention relates to methods, apparatus and systems for audio playback via a personal audio device following a biometric process. A personal audio device may be used to obtain ear model data for authenticating a user via an ear biometric authentication system. Owing to that successful authentication, the electronic device is informed of the person who is listening to audio playback from the device. Thus the device can implement one or more playback settings which are specific to that authorised user.

Abstract: A knowledge interface is provided that interacts with a user to identify a solution to a customer problem or issue with respect to a particular product or service. The knowledge interface includes data processing functionality configured to dynamically generate a number of components that are presented in at least one display window for display to the user. The components include first data identifying a set of predetermined symptoms linked to the problem or issue and related interface elements for classification of the set of predetermined symptoms, second data identifying a set of predetermined root causes linked to the set of predetermined symptoms and related interface elements for classification of the set of predetermined root causes, and third data identifying a set of solutions linked to the set of predetermined root causes. The third data identifies a best solution based upon the predetermined root causes and their associated class designations.

Abstract: The present invention relates to methods, apparatus and systems for audio playback via a personal audio device following a biometric process. A personal audio device may be used to obtain ear model data for authenticating a user via an ear biometric authentication system. Owing to that successful authentication, the electronic device is informed of the person who is listening to audio playback from the device. Thus the device can implement one or more playback settings which are specific to that authorised user.

Abstract: The invention relates to a method of detecting a disease state or disease susceptibility in a mammalian subject which comprises detecting an antibody in a test sample comprising a bodily fluid from said mammalian subject wherein said antibody is a biological marker of a disease state or disease susceptibility, the method comprising: (a) contacting said test sample with a plurality of different amounts of an antigen specific for said antibody, (b) detecting the amount of specific binding between said antibody and said antigen, (c) plotting or calculating a curve of the amount of said specific binding versus the amount of antigen for each amount of antigen used in step (a) and (d) determining the presence or absence of said disease state or disease susceptibility based upon the amount of specific binding between said antibody and said antigen at each different antigen concentration used.

Abstract: The invention relates to a method of detecting a disease state or disease susceptibility in a mammalian subject which comprises detecting an antibody in a test sample comprising a bodily fluid from said mammalian subject wherein said antibody is a biological marker of a disease state or disease susceptibility, the method comprising: (a) contacting said test sample with a plurality of different amounts of an antigen specific for said antibody, (b) detecting the amount of specific binding between said antibody and said antigen, (c) plotting or calculating a curve of the amount of said specific binding versus the amount of antigen for each amount of antigen used in step (a) and (d) determining the presence or absence of said disease state or disease susceptibility based upon the amount of specific binding between said antibody and said antigen at each different antigen concentration used.

Abstract: The present invention comprises methods and compositions for detecting cancer in an individual comprising autoantibodies to cancer-associated antigens. Specifically, the present invention comprises methods and compositions for detecting autoantibodies to cancer-associated antigen in a bodily fluid as well as use of said autoantibodies as a means to detect the presence of cancer-associated antigens.

Abstract: A knowledge interface is provided that interacts with a user to identify a solution to a customer problem or issue with respect to a particular product or service. The knowledge interface includes data processing functionality configured to dynamically generate a number of components that are presented in at least one display window for display to the user. The components include first data identifying a set of predetermined symptoms linked to the problem or issue and related interface elements for classification of the set of predetermined symptoms, second data identifying a set of predetermined root causes linked to the set of predetermined symptoms and related interface elements for classification of the set of predetermined root causes, and third data identifying a set of solutions linked to the set of predetermined root causes. The third data identifies a best solution based upon the predetermined root causes and their associated class designations.

Abstract: The invention relates to a method of detecting a disease state or disease susceptibility in a mammalian subject which comprises detecting an antibody in a test sample comprising a bodily fluid from said mammalian subject wherein said antibody is a biological marker of a disease state or disease susceptibility, the method comprising: (a) contacting said test sample with a plurality of different amounts of an antigen specific for said antibody, (b) detecting the amount of specific binding between said antibody and said antigen, (c) plotting or calculating a curve of the amount of said specific binding versus the amount of antigen for each amount of antigen used in step (a) and (d) determining the presence or absence of said disease state or disease susceptibility based upon the amount of specific binding between said antibody and said antigen at each different antigen concentration used.

Abstract: The invention relates to a method of detecting a disease state or disease susceptibility in a mammalian subject which comprises detecting an antibody in a test sample comprising a bodily fluid from said mammalian subject wherein said antibody is a biological marker of a disease state or disease susceptibility, the method comprising: (a) contacting said test sample with a plurality of different amounts of an antigen specific for said antibody, (b) detecting the amount of specific binding between said antibody and said antigen, (c) plotting or calculating a curve of the amount of said specific binding versus the amount of antigen for each amount of antigen used in step (a) and (d) determining the presence or absence of said disease state or disease susceptibility based upon the amount of specific binding between said antibody and said antigen at each different antigen concentration used.

Abstract: An apparatus 2 comprising a cryogenic chamber 4 and a galvanic input interface 6 to the cryogenic chamber 4 configured to receive a lower amplitude electric current 8. A converter 10 is located within the cryogenic chamber 4 and configured to convert the lower amplitude electric current 8, provided by the galvanic input interface 6, to a higher amplitude electric current 12 for supply to a load 14 within the cryogenic chamber 4. A controller 16 is configured to control the converter 10 and to detect the onset of quench by comparing the duration of the charge/discharge cycle of the convertor with a stored value. The controller 16 may also compare an instantaneous value of load current with a stored value of load current.

Abstract: The invention relates to a method of detecting a disease state or disease susceptibility in a mammalian subject which comprises detecting an antibody in a test sample comprising a bodily fluid from said mammalian subject wherein said antibody is a biological marker of a disease state or disease susceptibility, the method comprising: (a) contacting said test sample with a plurality of different amounts of an antigen specific for said antibody, (b) detecting the amount of specific binding between said antibody and said antigen, (c) plotting or calculating a curve of the amount of said specific binding versus the amount of antigen for each amount of antigen used in step (a) and (d) determining the presence or absence of said disease state or disease susceptibility based upon the amount of specific binding between said antibody and said antigen at each different antigen concentration used.

Abstract: Tumour marker proteins and their preparation from fluids from one or more cancer patients, wherein said fluids are those which collect in a body cavity or space which is naturally occurring or which is the result of cancer or medical intervention for cancer. The present application also relates to preparation of tumour marker proteins from excretions taken from patients with cancer. The tumour marker proteins are useful as immunoassay reagents in the detection of cancer-associated anti-tumour marker autoantibodies.

Abstract: The invention relates to tumor marker proteins and their preparation from fluids from one or more cancer patients, wherein said fluids are those which collect in a body cavity or space which is naturally occurring or which is the result of cancer or medical intervention for cancer. The invention also relates to preparation of tumor marker proteins from excretions taken from patients with cancer. The tumor marker proteins are useful as immunoassay reagents in the detection of cancer-associated anti-tumor marker autoantibodies.

Abstract: The present invention comprises methods and compositions for detecting cancer in an individual comprising autoantibodies to cancer-associated antigens. Specifically, the present invention comprises methods and compositions for detecting autoantibodies to cancer-associated antigen in a bodily fluid as well as use of said autoantibodies as a means to detect the presence of cancer-associated antigens.

Abstract: A package having two or more compartments that is made from a laminated flexible film is disclosed. The compartments store products having different requirements for in relation to contact of oxygen and other gases from outside the compartments or release of oxygen and other gases generated by the products in the compartments. The laminated film has different OTR or GTR levels in different sections of the film to suit the different requirements for oxygen and other gases of the products in the compartments. A method of manufacturing the package is also disclosed.

Abstract: The invention relates to a method of detecting a disease state or disease susceptibility in a mammalian subject which comprises detecting an antibody in a test sample comprising a bodily fluid from said mammalian subject wherein said antibody is a biological marker of a disease state or disease susceptibility, the method comprising: (a) contacting said test sample with a plurality of different amounts of an antigen specific for said antibody, (b) detecting the amount of specific binding between said antibody and said antigen, (c) plotting or calculating a curve of the amount of said specific binding versus the amount of antigen for each amount of antigen used in step (a) and (d) determining the presence or absence of said disease state or disease susceptibility based upon the amount of specific binding between said antibody and said antigen at each different antigen concentration used.

Abstract: A method of enabling a wireless information device to access data from several data services providers in which the method comprises the step of the device using an extensible framework which handles data passing to and from several applications resident on the device, the framework being shared by each of the applications resident on the device and also being shared by each of the data services providers.